![Kyle Dempsey](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 5 798 $ al 31/05/2026
Kyle Dempsey currently works at GT Medical Technologies, Inc., as Director, HLS Therapeutics, Inc., as Independent Director from 2022, MVM Partners LLP, as Partner, and MVM Partners LLC, as Partner from 2017.
Dr. Dempsey also formerly worked at OptiNose, Inc., as Independent Director from 2021 to 2025.
Dr. Dempsey received his undergraduate degree from Bowdoin College, doctorate degree from Harvard Medical School, and Masters Business Admin degree from Harvard Business School.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
HLS THERAPEUTICS, INC. 0,01 % | 31/03/2026 | 1.765 ( 0,01 % ) | 5 798 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| HLS THERAPEUTICS INC. | Director/Miembro de la Junta | 29/11/2022 |
MVM Partners LLC
 MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager | Inversor de Capital Privado | 01/09/2017 |
GT Medical Technologies, Inc.
 GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Director/Miembro de la Junta | - |
MVM Partners LLP
 MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Inversor de Capital Privado | - |
| Empresas | Cargo | Fin |
|---|---|---|
| OPTINOSE, INC. | Director/Miembro de la Junta | 21/05/2025 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 8 |
|---|---|
OptiNose, Inc.
 OptiNose, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops and commercializes products for patients treated by ear, nose, throat and allergy diseases | Health Technology |
MVM Partners LLP
MVM Partners LLP Investment ManagersFinance MVM Partners invests in companies located across the globe. The firm focuses on healthcare and life sciences sectors. It provides financing for growth capital requirements with an investment size of USD 20 - 100 million. | Finance |
Bowdoin College
 Bowdoin College Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Business School
 Harvard Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
MVM Partners LLC
MVM Partners LLC Investment ManagersFinance Functions as an alternative investment manager | Finance |
GT Medical Technologies, Inc.
GT Medical Technologies, Inc. Medical SpecialtiesHealth Technology Develops and manufactures medical equipment for the treatment of brain tumors | Health Technology |
HLS Therapeutics, Inc.
 HLS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
